Document is current
Any future updates will be listed below
-
Authors
Ferlazzo, Giorgia Maria https://orcid.org/0000-0003-1048-7708
Gambetta, Anna Maria https://orcid.org/0009-0005-2342-3051
Amato, Sonia https://orcid.org/0009-0005-8984-8239
Cannizzaro, Noemi https://orcid.org/0009-0008-0071-6291
Angiolillo, Silvia
Arboit, Mattia https://orcid.org/0000-0001-7286-5589
Diamante, Linda https://orcid.org/0000-0002-3268-1707
Carbognin, Elena https://orcid.org/0000-0001-6591-6915
Romani, Patrizia https://orcid.org/0000-0002-1149-4304
La Torre, Federico https://orcid.org/0009-0009-7843-5761
Galimberti, Elena
Pflug, Florian https://orcid.org/0000-0002-5344-5359
Luoni, Mirko https://orcid.org/0000-0002-5006-1827
Giannelli, Serena https://orcid.org/0000-0002-6787-7793
Pepe, Giuseppe
Capocci, Luca
Di Pardo, Alba
Vanzani, Paola https://orcid.org/0000-0002-9444-3579
Zennaro, Lucio https://orcid.org/0000-0001-6127-9912
Broccoli, Vania https://orcid.org/0000-0003-4050-0926
Leeb, Martin https://orcid.org/0000-0001-5114-4782
Moro, Enrico https://orcid.org/0000-0003-3166-8102
Maglione, Vittorio https://orcid.org/0000-0002-6906-7372
Martello, Graziano https://orcid.org/0000-0001-5520-085X
- License Information
-
More Information
Article History
Received: 31 March 2021
Accepted: 19 June 2023
First Online: 5 July 2023
Competing interests
: G.M.F., A.M.G., M.Le. and G.M., files a patent application about the use of the suppressors identified in this study as therapeutic agents for polyQ diseases (Therapeutic factors for the treatment of PolyQ disease - Patent Application No. PCT/IB2023/051156 filed on 11 February 2022). Patent applicants are the institutions of Telethon Foundation, University of Padova and University of Wien. The remaining authors declare no competing interests.
